<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hamilton FW</submitter><funding>University of Bristol NIHR Biomedical Research Centre</funding><funding>MRC Integrative Epidemiology Unit</funding><funding>CRUK Integrative Cancer Epidemiology Programme</funding><funding>National Institute for Health Research (NIHR)</funding><funding>GW4-CAT Wellcome Trust Doctoral Fellowship Scheme</funding><funding>Wellcome Trust</funding><funding>Academy of Medical Sciences</funding><pagination>e000467</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10347488</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>2(1)</volume><pubmed_abstract>&lt;h4>Objectives&lt;/h4>To compare associations between the Gilbert syndrome genotype in European populations, measured bilirubin concentrations, genetically predicted bilirubin using this genotype, and a wide range of health outcomes in a large cohort.&lt;h4>Design&lt;/h4>Cohort study including observational, genetic, and Mendelian randomisation analyses.&lt;h4>Setting&lt;/h4>22 centres across England, Scotland, and Wales in UK Biobank (2006-10), with replication in a national Finnish cohort (FinnGen).&lt;h4>Participants&lt;/h4>463 060 participants in the UK Biobank were successfully genotyped for a genetic variant (rs887829) that is strongly associated with Gilbert syndrome and 438 056 participants had measured bilirubin concentrations with linked electronic health record data coded using the tenth edition of </pubmed_abstract><journal>BMJ medicine</journal><pubmed_title>Effect of bilirubin and Gilbert syndrome on health: cohort analysis of observational, genetic, and Mendelian randomisation associations.</pubmed_title><pmcid>PMC10347488</pmcid><funding_grant_id>SGL029\1006</funding_grant_id><funding_grant_id>MC_UU_00011/1</funding_grant_id><funding_grant_id>BRC-1215-2001</funding_grant_id><funding_grant_id>222894/Z/21/Z</funding_grant_id><funding_grant_id>CL-2022-25-006</funding_grant_id><funding_grant_id>202802/Z/16/Z</funding_grant_id><funding_grant_id>C18281/A29019</funding_grant_id><pubmed_authors>Timpson NJ</pubmed_authors><pubmed_authors>Hamilton FW</pubmed_authors><pubmed_authors>Hamilton W</pubmed_authors><pubmed_authors>Abeysekera K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effect of bilirubin and Gilbert syndrome on health: cohort analysis of observational, genetic, and Mendelian randomisation associations.</name><description>&lt;h4>Objectives&lt;/h4>To compare associations between the Gilbert syndrome genotype in European populations, measured bilirubin concentrations, genetically predicted bilirubin using this genotype, and a wide range of health outcomes in a large cohort.&lt;h4>Design&lt;/h4>Cohort study including observational, genetic, and Mendelian randomisation analyses.&lt;h4>Setting&lt;/h4>22 centres across England, Scotland, and Wales in UK Biobank (2006-10), with replication in a national Finnish cohort (FinnGen).&lt;h4>Participants&lt;/h4>463 060 participants in the UK Biobank were successfully genotyped for a genetic variant (rs887829) that is strongly associated with Gilbert syndrome and 438 056 participants had measured bilirubin concentrations with linked electronic health record data coded using the tenth edition of </description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2026-06-16T06:48:42.884Z</modification><creation>2024-11-20T16:53:21.132Z</creation></dates><accession>S-EPMC10347488</accession><cross_references><pubmed>37456363</pubmed><doi>10.1136/bmjmed-2022-000467</doi></cross_references></HashMap>